Acura Pharma (ACUR) Reports Q4 Loss of $0.06
Tweet
Share
E-mailGet Alerts ACUR Hot Sheet
Join SI Premium – FREE
Acura Pharma (NASDAQ: ACUR) reported Q4 EPS of ($0.06), versus ($0.07) reported last year.
For earnings history and earnings-related data on Acura Pharma (ACUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Benchmark Reiterates Buy Rating on Marvell (MRVL) Following Earnings
- NewtekOne cuts EPS guidance, shifts focus to net interest income
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
